Safety and tolerability of multiple ascending doses of once-weekly GL0034 (utreglutide) in healthy individuals

被引：0

作者：

Burade, V. ^{[1
]}

Thennati, R. ^{[1
]}

Natarajan, M. ^{[1
]}

Shahi, P. ^{[1
]}

Nagaraja, R. ^{[1
]}

Panchal, S. ^{[1
]}

Agrawal, S. ^{[1
]}

Jandrain, B. ^{[2
,3
]}

Duvauchelle, T. ^{[4
]}

Garcia-Ocana, A. ^{[5
]}

Rutter, G. A. ^{[6
,7
]}

Pratley, R. E. ^{[8
]}

Thorens, B. ^{[9
]}

Vilsboll, T. ^{[10
,11
]}

机构：

[1] Sun Pharmaceut Ind Ltd, High Impact Innovat Sustainable Hlth Solut HISH, Vadodara, Gujarat, India

[2] Acad Hosp Leige, Clin Pharmacol Unit, ATC Co, Liege, Belgium

[3] Acad Hosp Leige, Div Diabet Nutr & Metab Disorders, Liege, Belgium

[4] Phaster1, La Plessis Trevise, France

[5] Arthur Riggs Diabet & Metab Res Inst, Dept Mol & Cellular Endocrinol, Ruth B & Robert K Lanman Endowed Chair Gene Regul, Duarte, CA USA

[6] Univ Montreal, CR CHUM, Montreal, PQ, Canada

[7] Imperial Coll London, Div Diabet Endocrinol & Metab, Sect Cell Biol & Funct Genom, Dept Metab Digest Reprod, London, England

[8] AdventHlth Translat Res Inst, Orlando, FL USA

[9] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland

[10] Steno Diabet Ctr Copenhagen, Clin Res, Herlev, Denmark

[11] Univ Copenhagen, Copenhagen, Denmark

来源：

DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

641

引用

页码：S323 / S323

页数：1

共 50 条

[21] Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Sotagliflozin After Multiple Ascending Doses in Chinese Healthy Subjects
He, Xuemei
Gao, Xin
Xie, Panpan
Liu, Yuan
Bai, Wenjing
Liu, Yue
Shi, Aixin
DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 2967 - 2980
[22] Safety, Tolerability and Pharmacokinetics of Single Ascending and Multiple Oral Doses of Tegoprazan in Healthy Chinese Subjects
Jinjie He
Guoying Cao
Jicheng Yu
Jingjing Wang
Nengneng Cheng
Jufang Wu
Jing Zhang
Xiaojie Wu
Basheng Zhang
Jiayan Lu
Shangzhi Chen
Clinical Drug Investigation, 2021, 41 : 89 - 97
[23] Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of TAK-935 in Healthy Subjects
Wang, Shining
Chen, Grace
Uz, Tolga
Affinito, John
NEUROLOGY, 2018, 90
[24] Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-Ascending Doses of Sunobinop in Healthy Participants
Cipriano, Alessandra
Kapil, Ram P.
Zhou, Mingyan
Shet, Manjunath S.
Whiteside, Garth T.
Willsie, Sandra K.
Harris, Stephen C.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (07): : 790 - 800
[25] A study to evaluate the safety, tolerability, and pharmacokinetics of multiple weekly doses of intravenous dalbavancin in healthy subjects
Dunne, Michael W.
Sprenger, Craig
Moriarty, Susan
PHARMACOTHERAPY, 2013, 33 (10): : E261 - E261
[26] Safety, tolerability, pharmacokinetics and pharmacodynamics of GZR4, a novel once-weekly basal insulin, in healthy participants: A randomized trial
Tang, Chengyong
Su, Rui
Wan, Lei
Zhu, Mingxue
Pu, Junliang
Hao, Chunyue
Zhao, Jing
He, Anshun
Xie, Tian
Li, Yue
Chen, Wei
Gan, Zhong-Ru
DIABETES OBESITY & METABOLISM, 2025,
[27] Safety, tolerability, pharmacokinetics and pharmacodynamics of ascending single and multiple doses of lecozotan in healthy young and elderly subjects
Patat, Alain
Parks, Virginia
Raje, Sangeeta
Plotka, Anna
Chassard, Didier
Le Coz, F.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 67 (03) : 299 - 308
[28] Safety and tolerability of once-weekly GLP-1 receptor agonists in type 2 diabetes
Trujillo, Jennifer
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 : 43 - 60
[29] Pharmacokinetics, Safety and Tolerability of Once-Weekly Subcutaneous Semaglutide in Healthy Chinese Subjects: A Double-Blind, Phase 1, Randomized Controlled Trial
Shi, Aixin
Xie, Panpan
Nielsen, Lasse Lykke
Skjoth, Trine Vang
He, Xuemei
Haugaard, Sine Pfeiffer
ADVANCES IN THERAPY, 2021, 38 (01) : 550 - 561
[30] Pharmacokinetics, Safety and Tolerability of Once-Weekly Subcutaneous Semaglutide in Healthy Chinese Subjects: A Double-Blind, Phase 1, Randomized Controlled Trial
Aixin Shi
Panpan Xie
Lasse Lykke Nielsen
Trine Vang Skjøth
Xuemei He
Sine Pfeiffer Haugaard
Advances in Therapy, 2021, 38 : 550 - 561

← 1 2 3 4 5 →